Curavista bv is a pioneering ICT company established in 2002 that specializes in developing innovative healthcare IT solutions. Their flagship product, formerly available online, personalizes health management for both patients and healthcare professionals, significantly improving cost-effectiveness in healthcare delivery.
With a strong presence across various medical fields, including asthma, COPD, diabetes, and several chronic and rare diseases, Curavista has accumulated substantial expertise over its two decades of operation. Its award-winning solutions are accessible in 11 languages and cater to over 400,000 patients, marking a substantial footprint in the digital health landscape.
Despite its achievements, details on recent funding rounds or investor partnerships remain undisclosed. For investors, Curavista bv stands as a potentially untapped opportunity given its robust client base and technological solutions in a market that prioritizes efficient, patient-centered care advancements.